Načítá se...
Folic acid phenotype (FAP) is a superior biomarker predicting response to pemetrexed-based chemotherapy in malignant pleural mesothelioma
BACKGROUND: Malignant pleural mesothelioma (MPM) is a rare tumor linked to a dismal prognosis. Even the most effective chemotherapeutical regime of pemetrexed combined with cisplatin leads to a remission-rate of only about 40%. The reasons for the rather poor efficacy remain largely unknown. RESULTS...
Uloženo v:
Vydáno v: | Oncotarget |
---|---|
Hlavní autoři: | , , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Impact Journals LLC
2017
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5514925/ https://ncbi.nlm.nih.gov/pubmed/28415584 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16398 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|